Biopolym. Cell. 2013; 29(2):131-135.
Genomics, Transcriptomics and Proteomics
Interaction of ubiquitin ligase CBL with LMP2A
protein of Epstein-Barr virus occurs via PTB domain
of CBL and does not depend on adaptor ITSN1
1Dergai O. V., 1Dergai M. V., 1Gudkova D. O., 1Tsyba L. O., 1Skrypkina I. Ya., 1Rynditch A. V.
- State Key Laboratory of Molecular and Cellular Biology
Institute of Molecular Biology and Genetics, NAS of Ukraine
150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03680
Abstract
Aim. Previously Latent membrane protein 2A (LMP2A) of Epstein-Barr virus was found to be ubiquitylated by CBL ubiquitin ligase but no direct interaction of LMP2A with CBL was reported. We aimed to explore this interaction and study a possibility of adaptor protein involvement. Taking into consideration that both LMP2A and CBL were shown to interact with endocytic adaptor protein intersectin 1 (ITSN1), we assumed that the latter could serve as a scaffold for LMP2A/CBL complex. Methods. We used an immunofluorescence and coimmuno- precipitation approaches to test a mutual complex formation of ITSN1, CBL and LMP2A proteins. Results. LMP2A coimmunoprecipitated with CBL while LMP2A did not interact with CBL G306E mutant harboring inactive phosphotyrosine-binding domain. We observed a triple colocalization of ITSN1, CBL and LMP2A signals in MCF-7 cells as well as coprecipitation of all mentioned proteins. Overexpression of ITSN1 did not affect the efficiency of complex formation of LMP2A with CBL. Moreover, LMP2A mutant unable to interact with ITSN1 was readily precipitated with CBL. Conclusions. LMP2A can be engaged in the complex together with endocytic adaptor ITSN1 and ubiquitin ligase CBL. We show that PTB domain of CBL is responsible for interaction with LMP2A. ITSN1 is not required for LMP2A recruiting to CBL.
Keywords: intersectin 1, CBL, LMP2A, Epstein-Barr virus
Full text: (PDF, in English)
References
[1]
Pang M. F., Lin K. W., Peh S. C. The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer Cell Mol. Biol. Lett 2009 14, N 2 P. 222–247.
[2]
Heussinger N., Buttner M., Ott G., Brachtel E., Pilch B. Z., Kremmer E., Niedobitek G. Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBVassociated nasopharyngeal carcinoma J. Pathol 2004 203, N 2 P. 696–699.
[3]
Miller C. L., Lee J. H., Kieff E., Longnecker R. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking Proc. Natl Acad. Sci. USA 1994 91, N 2 P. 772–776.
[4]
Swart R., Ruf I. K., Sample J., Longnecker R. Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway J. Virol 2000 74, N 22 P. 10838–10845.
[5]
Fukuda M., Longnecker R. Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/Akt Pathway J. Virol 2007 81, N 17 P. 9299–9306.
[6]
Schaadt E., Baier B., Mautner J., Bornkamm G. W., Adler B. Epstein-Barr virus latent membrane protein 2A mimics B-cell receptor-dependent virus reactivation J. Gen. Virol 2005 86, Pt 3 P. 551–559.
[7]
Mancao C., Hammerschmidt W. Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for Bcell survival Blood 2007 110, N 10 P. 3715–3721.
[8]
Winberg G., Matskova L., Chen F., Plant P., Rotin D., Gish G., Ingham R., Ernberg I., Pawson T. Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases Mol. Cell. Biol 2000 20, N 22 P. 8526–8535.
[9]
Ikeda A., Caldwell R. G., Longnecker R., Ikeda M. Itchy, a Nedd4 ubiquitin ligase, downregulates latent membrane protein 2A activity in B-cell signaling J. Virol 2003 77, N 9 P. 5529–5534.
[10]
Ikeda M., Longnecker R. The c-CBL proto-oncoprotein downregulates EBV LMP2A signaling Virology 2009 385, N 1 P. 183–191.
[11]
Martin N. P., Mohney R. P., Dunn S., Das M., Scappini E., O'Bryan J. P. Intersectin regulates epidermal growth factor receptor endocytosis, ubiquitylation, and signaling Mol. Pharmacol 2006 70, N 5 P. 1643–1653.
[12]
Dergai M., Skrypkina I., Dergai O., Tsyba L., Novokhatska O., Filonenko V., Drobot L., Rynditch A. Identification and characterization of a novel mammalian isoform of the endocytic adaptor ITSN1 Gene 2011 485, N 2 P. 120–129.
[13]
Dergai O., Dergai M., Skrypkina I., Matskova L., Tsyba L., Gudkova D., Rynditch A. The LMP2A protein of Epstein-Barr virus regulates phosphorylation of ITSN1 and Shb adaptors by tyrosine kinases Cell Signal 2013 25, N 1 P. 33–40.
[14]
Pechstein A., Shupliakov O., Haucke V. Intersectin 1: a versatile actor in the synaptic vesicle cycle Biochem. Soc. Trans 2010 38, Pt 1 P. 181–186.
[15]
Tsyba L., Nikolaienko O., Dergai O., Dergai M., Novokhatska O., Skrypkina I., Rynditch A. Intersectin multidomain adaptor proteins: regulation of functional diversity Gene 2011 473, N 2 P. 67–75.
[16]
Henne W. M., Boucrot E., Meinecke M., Evergren E., Vallis Y., Mittal R., McMahon H. T. FCHo proteins are nucleators of clathrin-mediated endocytosis Science 2010 328, N 5983 P.1281–1284.
[17]
Dergai O., Novokhatska O., Dergai M., Skrypkina I., Tsyba L., Moreau J., Rynditch A. Intersectin 1 forms complexes with SGIP1 and Reps1 in clathrin-coated pits Biochem. Biophys. Res. Commun 2010 402, N 2 P. 408–413.
[18]
Dergai O. V., Dergai M. V., Skrypkina I. Ya., Tsyba L. O., Yaruchik A. M., Rynditch A. V. Amphiphysin 1 and 2 interact with latent membrane protein 2A of Epstein-Barr virus and regulate its exosomal secretion Biopolym. Cell 2012 28, N 3 P. 243– 238.
[19]
Nikolaienko O., Skrypkina I., Tsyba L., Fedyshyn Y., Morderer D., Buchman V., de la Luna S., Drobot L., Rynditch A. Intersectin 1 forms a complex with adaptor protein Ruk/CIN85 in vivo independently of epidermal growth factor stimulation Cell Signal 2009 21, N 5 P. 753–759.
[20]
Morderer D., Nikolaienko O., Skrypkina I., Cherkas V., Tsyba L., Belan P., Rynditch A. Endocytic adaptor protein intersectin 1 forms a complex with microtubule stabilizer STOP in neurons Gene 2012 505, N 2 P. 360–364.
[21]
Joazeiro C. A., Wing S. S., Huang H., Leverson J. D., Hunter T., Liu Y. C. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase Science 1999 286, N 5438 P. 309–312.
[22]
Schmidt M. H., Dikic I. The CBL interactome and its functions Nat. Rev. Mol. Cell. Biol 2005 6, N 12 P. 907–918.
[23]
Rao N., Dodge I., Band H. The CBL family of ubiquitin ligases: critical negative regulators of tyrosine kinase signaling in the immune system J. Leukoc. Biol 2002 71, N 5 P. 753–763.
